Cargando…

Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer

PURPOSE: Oestrogen receptor-positive (ER+) and human epidermal receptor 2-negative (HER2–) breast cancers are classified as Luminal A or B based on gene expression, but immunohistochemical markers are used for surrogate subtyping. The aims of this study were to examine the agreement between molecula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lundgren, Christine, Bendahl, Pär-Ola, Borg, Åke, Ehinger, Anna, Hegardt, Cecilia, Larsson, Christer, Loman, Niklas, Malmberg, Martin, Olofsson, Helena, Saal, Lao H., Sjöblom, Tobias, Lindman, Henrik, Klintman, Marie, Häkkinen, Jari, Vallon-Christersson, Johan, Fernö, Mårten, Rydén, Lisa, Ekholm, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797629/ https://www.ncbi.nlm.nih.gov/pubmed/31432367 http://dx.doi.org/10.1007/s10549-019-05378-7

Ejemplares similares

Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
por: Vallon-Christersson, Johan, et al.
Publicado: (2019)

RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
por: Staaf, Johan, et al.
Publicado: (2022)

Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
por: Larsson, Christer, et al.
Publicado: (2020)

Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
por: Brueffer, Christian, et al.
Publicado: (2018)

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
por: Olsson, Eleonor, et al.
Publicado: (2011)

Minimizing inequality in access to precision medicine in breast cancer by real‐time population‐based molecular analysis in the SCAN‐B initiative
por: Rydén, L., et al.
Publicado: (2018)

The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome
por: Brueffer, Christian, et al.
Publicado: (2020)

Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
por: Dahlgren, Malin, et al.
Publicado: (2021)

Refinement of breast cancer molecular classification by miRNA expression profiles
por: Søkilde, Rolf, et al.
Publicado: (2019)

How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer
por: Saghir, Hani, et al.
Publicado: (2022)

PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
por: Lundgren, Christine, et al.
Publicado: (2022)

The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine
por: Saal, Lao H, et al.
Publicado: (2015)

St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial
por: Falck, Anna-Karin, et al.
Publicado: (2013)

Whole-genome-sequencing of triple negative breast cancers in a population-based clinical study
por: Staaf, Johan, et al.
Publicado: (2019)

Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
por: Glodzik, Dominik, et al.
Publicado: (2020)

Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer
por: Alkner, Sara, et al.
Publicado: (2016)

The CD44(+)/CD24(- )phenotype is enriched in basal-like breast tumors
por: Honeth, Gabriella, et al.
Publicado: (2008)

Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up
por: Lundgren, Christine, et al.
Publicado: (2020)

Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
por: Holm, Karolina, et al.
Publicado: (2010)

Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
por: Lundgren, Christine, et al.
Publicado: (2023)

Prediction of outcome after diagnosis of metachronous contralateral breast cancer
por: Alkner, Sara, et al.
Publicado: (2011)

Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study
por: Demircan, Kamil, et al.
Publicado: (2023)

Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study
por: Bengtsson, Ylva, et al.
Publicado: (2023)

Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
por: Romero, Quinci, et al.
Publicado: (2011)

Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor
por: Narbe, Ulrik, et al.
Publicado: (2014)

An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells
por: Holm, Karolina, et al.
Publicado: (2016)

St Gallen molecular subtypes in screening‐detected and symptomatic breast cancer in a prospective cohort with long‐term follow‐up
por: Falck, A. K., et al.
Publicado: (2016)

Co-localization of CD169(+) macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression
por: Björk Gunnarsdottir, Frida, et al.
Publicado: (2020)

Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
por: Winter, C., et al.
Publicado: (2016)

PAM50 Intrinsic Subtype Profiles in Primary and Metastatic Breast Cancer Show a Significant Shift toward More Aggressive Subtypes with Prognostic Implications
por: Jørgensen, Charlotte Levin Tykjær, et al.
Publicado: (2021)

BASE - 2nd generation software for microarray data management and analysis
por: Vallon-Christersson, Johan, et al.
Publicado: (2009)

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
por: Jansson, Sara, et al.
Publicado: (2018)

Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort study
por: Demircan, Kamil, et al.
Publicado: (2021)

Subtype and cell type specific expression of lncRNAs provide insight into breast cancer
por: Bjørklund, Sunniva Stordal, et al.
Publicado: (2022)

Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications
por: Kimbung, Siker, et al.
Publicado: (2015)

Autoimmunity to selenoprotein P predicts breast cancer recurrence
por: Demircan, Kamil, et al.
Publicado: (2022)

The Three Receptor Tyrosine Kinases c-KIT, VEGFR2 and PDGFRα, Closely Spaced at 4q12, Show Increased Protein Expression in Triple-Negative Breast Cancer
por: Jansson, Sara, et al.
Publicado: (2014)

Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer
por: Veerla, Srinivas, et al.
Publicado: (2023)

Psychological Resilience and Health-Related Quality of Life in 418 Swedish Women with Primary Breast Cancer: Results from a Prospective Longitudinal Study
por: Mohlin, Åsa, et al.
Publicado: (2021)

Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
por: Tutzauer, Julia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_coo7ucqt9kqqt3fotmjqbcp6qb